ESMA LIBRARY
REFINE YOUR SEARCH
Sections
- (-) Remove COVID-19 filter COVID-19
- (-) Remove Corporate Governance filter Corporate Governance
- (-) Remove Risk Analysis & Economics - Markets Infrastructure Investors filter Risk Analysis & Economics - Markets Infrastructure Investors
- (-) Remove Speeches filter Speeches
- (-) Remove Audit filter Audit
- Corporate Information (96) Apply Corporate Information filter
- MiFID - Secondary Markets (37) Apply MiFID - Secondary Markets filter
- Post Trading (37) Apply Post Trading filter
- Corporate Disclosure (33) Apply Corporate Disclosure filter
- Brexit (30) Apply Brexit filter
- CESR Archive (30) Apply CESR Archive filter
- Credit Rating Agencies (28) Apply Credit Rating Agencies filter
- MiFID - Investor Protection (23) Apply MiFID - Investor Protection filter
- Board of Supervisors (21) Apply Board of Supervisors filter
- Fund Management (20) Apply Fund Management filter
- Press Releases (18) Apply Press Releases filter
- IFRS Supervisory Convergence (15) Apply IFRS Supervisory Convergence filter
- Joint Committee (14) Apply Joint Committee filter
- Supervisory convergence (13) Apply Supervisory convergence filter
- Market Integrity (12) Apply Market Integrity filter
- Innovation and Products (9) Apply Innovation and Products filter
- Trade Repositories (8) Apply Trade Repositories filter
- Benchmarks (7) Apply Benchmarks filter
- MiFID II: Transparency Calculations and DVC (7) Apply MiFID II: Transparency Calculations and DVC filter
- Planning reporting budget (7) Apply Planning reporting budget filter
- Prospectus (6) Apply Prospectus filter
- Securities Financing Transactions (6) Apply Securities Financing Transactions filter
- Short Selling (6) Apply Short Selling filter
- Market Abuse (5) Apply Market Abuse filter
- Warnings and publications for investors (5) Apply Warnings and publications for investors filter
- Corporate Finance (4) Apply Corporate Finance filter
- Management Board (4) Apply Management Board filter
- Sustainable finance (4) Apply Sustainable finance filter
- Transparency (4) Apply Transparency filter
- IAS Regulation (3) Apply IAS Regulation filter
- Securitisation (3) Apply Securitisation filter
- Guidelines and Technical standards (2) Apply Guidelines and Technical standards filter
- Trading (2) Apply Trading filter
- CCP Directorate (1) Apply CCP Directorate filter
- Crowdfunding (1) Apply Crowdfunding filter
- International cooperation (1) Apply International cooperation filter
- Securities and Markets Stakeholder Group (1) Apply Securities and Markets Stakeholder Group filter
Type of document
- (-) Remove Statement filter Statement
- (-) Remove Annual Report filter Annual Report
- (-) Remove Q&A filter Q&A
- Speech (145) Apply Speech filter
- Reference (43) Apply Reference filter
- Report (36) Apply Report filter
- Final Report (35) Apply Final Report filter
- Press Release (35) Apply Press Release filter
- Letter (20) Apply Letter filter
- Opinion (11) Apply Opinion filter
- Consultation Paper (5) Apply Consultation Paper filter
- Decision (5) Apply Decision filter
Date | Ref. | Title | Section | Type | Download | Info | Summary | Related Documents | Translated versions |
---|---|---|---|---|---|---|---|---|---|
12/10/2020 | ESMA22-105-1248 | Steven Maijoor Opening Statement for ECON Hearing 12 October 2020 | Board of Supervisors, Brexit, Corporate Information, COVID-19, Joint Committee, Speeches | Statement | PDF 134.36 KB |
||||
21/07/2020 | ESMA32-61-417 | Public Statement on supervisory action on accounting for COVID-19 lease modifications | COVID-19, IFRS Supervisory Convergence | Statement | PDF 120.44 KB |
||||
09/07/2020 | ESMA34-39-109 | Public statement on external support within the meaning of Article 35 of the MMF Regulation | COVID-19, Fund Management | Statement | PDF 118.34 KB |
||||
11/06/2020 | ESMA70-156-3070 | Statement_Access ETDs | COVID-19, MiFID - Secondary Markets, Post Trading | Statement | PDF 112.54 KB |
||||
20/05/2020 | ESMA32-63-972 | Implications of the COVID-19 outbreak on the half-yearly financial reports | Corporate Disclosure, COVID-19 | Statement | PDF 111.97 KB |
||||
14/05/2020 | ESMA50-158-2232 | ESMA supports ESRB actions to address COVID-related systemic vulnerabilities | COVID-19, Fund Management | Statement | PDF 81.33 KB |
||||
06/05/2020 | ESMA35-43-2391 | Reminder of firms’ MiFID II conduct of business obligations in the context of increasing retail investor activity | COVID-19, MiFID - Investor Protection | Statement | PDF 118.75 KB |
||||
04/05/2020 | ESMA71-99-1324 | Statement on bilateral margin RTS amendments in response to Covid-19 | COVID-19, Joint Committee, Post Trading, Press Releases | Statement | PDF 101.16 KB |
||||
09/04/2020 | ESMA70-155-9817 | ESMA postpones the publication dates of the annual transparency calculations for non-equity instruments and for the quarterly systematic internaliser data for non-equity instruments other than bonds | COVID-19, MiFID - Secondary Markets, MiFID II: Transparency Calculations and DVC | Statement | PDF 94.58 KB |
||||
09/04/2020 | ESMA80-187-546 | Actions to mitigate the impact of COVID-19 on the EU financial markets regarding the timeliness of fulfilling external audit requirements for interest rate benchmarks under the Benchmarks Regulation | Benchmarks, COVID-19 | Statement | PDF 89.31 KB |
||||
09/04/2020 | ESMA34-45-896 | Actions to mitigate the impact of COVID-19 on the deadlines for the publication of periodic reports by fund managers | COVID-19, Fund Management | Statement | PDF 113.03 KB |
||||
31/03/2020 | ESMA35-36-1919 | Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28 | COVID-19, MiFID - Investor Protection | Statement | PDF 89.84 KB |
||||
27/03/2020 | ESMA31-67-742 | Public statement on publication deadlines under the Transparency Directive | COVID-19, Transparency | Statement | PDF 88.72 KB |
||||
26/03/2020 | ESMA80-191-995 | COVID-19 Public Statement | COVID-19, Securities Financing Transactions | Statement | PDF 113.93 KB |
||||
25/03/2020 | ESMA32-63-951 | Accounting implications of the COVID-19 outbreak on the calculation of expected credit losses in accordance with IFRS 9 | Corporate Disclosure, COVID-19 | Statement | PDF 135.91 KB |
||||
20/03/2020 | ESMA70-1556-2485 | Public Statement Tick Sizes | COVID-19, MiFID - Secondary Markets | Statement | PDF 79.25 KB |
||||
20/03/2020 | ESMA35-43-2348 | ESMA Statement on COVID-19 telephone recording | COVID-19, MiFID - Investor Protection | Statement | PDF 114.12 KB |
||||
11/03/2020 | ESMA71-99-1290 | ESMA Statement on Markets and COVID-19 | Board of Supervisors, COVID-19 | Statement | PDF 87.99 KB |
||||
27/02/2020 | ESMA/2014/677-REV | Information on shareholder cooperation and acting in concert under the Takeover Bids Directive | Corporate Disclosure, Corporate Governance | Statement | PDF 368.97 KB |
The European Securities and Markets Authority (ESMA) has published an update to its statement on practices governed by the Takeover Bid Directive (TBD), focused on shareholder cooperation issues relating to acting in concert and the appointment of board members. The update concerns a change to the Croatian creep-in threshold and secondary threshold in Appendix B. The statement contains a White List of activities that shareholders can cooperate on without the presumption of acting in concert. It also contains information on how shareholders may cooperate in order to secure board member appointments by setting out factors that national authorities may take into account when considering whether shareholders are acting in concert.The statement is in response to a request by the European Commission for clarity on these issues, following its 2012 report on the application of the TBD. It is based on information collected about the TBD’s application and common practices across the European Economic Area (EEA). The statement was prepared by the Takeover Bids Network, a permanent working group, under ESMA’s auspices, that promotes the exchange of information on practices and application of the TBD across EEA. |
|||
11/04/2019 | ESMA31-62-780 | Q&A on Prospectus Related Topics | Brexit, Corporate Disclosure, Corporate Finance, Corporate Governance, Corporate Information, Prospectus, Supervisory convergence | Q&A | PDF 957.9 KB |